To establish expert consensus on psoriasis severity classification, assessment tools, treatment goals, and eligibility for systemic therapy in the Asia-Pacific region.
Approach:
Methodology: A modified Delphi process was used to gather expert opinions from dermatologists across the Asia-Pacific region.
Key Findings:
A total of 121 consensus statements were finalized, supporting a patient-centered and treatment-oriented approach.
The approach combines objective measures with quality-of-life impact and prioritizes high-impact sites.
There is a need for more consistent and region-specific psoriasis care in APAC.
Interpretation:
Limitations:
Variability in disease severity definitions and treatment escalation criteria across the region.
Inconsistent adoption of international guidelines due to regional healthcare differences.
Application of newly proposed GRAPPA and EULAR criteria in a longitudinal cohort identified progressively smaller groups of patients with early psoriatic arthritis who experienced persistently worse patient-reported outcomes.
